High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma
Clinical trial NCT00447356 · WITHDRAWN
Trial details
- NCT number
- NCT00447356
- Sponsor
- Hackensack Meridian Health
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-01-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.